Abstract

Objective To investigate the clinical value of serum bilirubin, malondialdehyde and uric acid in the diagnosis of coronary heart disease. Methods From February 2014 to March 2016, 116 patients with coronary heart disease were selected as the observation group, in the same period, 100 healthy persons were selected as control group, the serum uric acid, malondialdehyde and bilirubin levels of two groups were compared and analyzed, and the clinical effects of the combined detection of the above three indexes in the patients with different classification of coronary heart disease were analyzed. Results The serum bilirubin level in the observation group was significantly lower than that in the control group, the levels of malondialdehyde and uric acid were significantly higher than those in the control group, the difference was significant (P<0.05). With the severity of coronary artery stenosis, the serum bilirubin level decreased gradually, the MDA and uric acid increased gradually, and the differences were significant (P<0.05). Conclusions Coronary heart disease patients has low serum bilirubin, high uric acid and high performance of malondialdehyde, it can provide reliable basis for the diagnosis and condition monitoring of coronary heart disease with the results of biochemical indicators. Key words: Coronary heart disease; Uric acid; Malondialdehyde; Serum bilirubin; Joint diagnosis

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.